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Abstract 20 
 21 
Spinal muscular atrophy (SMA), an autosomal recessive disease caused by a decrease in 22 
levels of the Survival Motor Neuron (SMN) protein, is the most common genetic cause of 23 
infant mortality. Although neuromuscular pathology is the most severe feature of SMA, 24 
other organs and tissues, including the heart, are also known to be affected in both patients 25 
and animal models. Here, we provide new insights into changes occurring in the heart, 26 
predominantly at pre- and early-symptomatic ages, in the Taiwanese mouse model of 27 
severe SMA. Thinning of the interventricular septum and dilation of the ventricles occurred 28 
at pre- and early-symptomatic ages. However, the left ventricular wall was significantly 29 
thinner in SMA mice from birth, occurring prior to any overt neuromuscular symptoms. 30 
Alterations in collagen IV protein from birth indicated changes to the basement membrane 31 
and contributed to the abnormal arrangement of cardiomyocytes in SMA hearts. This raises 32 
the possibility that developmental defects, occurring prenatally, may contribute to cardiac 33 
pathology in SMA. In addition, cardiomyocytes in SMA hearts exhibited oxidative stress at 34 
pre-symptomatic ages and increased apoptosis during early-symptomatic stages of disease. 35 
Heart microvasculature was similarly decreased at an early-symptomatic age, likely 36 
contributing to the oxidative stress and apoptosis phenotypes observed. Finally, an 37 
increased incidence of blood ret ntion in SMA hearts post-fixation suggests the likelihood of 38 
functional defects, resulting in blood pooling. These pathologies mirror dilated 39 
cardiomyopathy, with clear consequences for heart function that would likely contribute to 40 
potential heart failure. Our findings add significant additional experimental evidence in 41 
support of the requirement to develop systemic therapies for SMA capable of treating non-42 
neuromuscular pathologies.    43 
 44 
Introduction 45 
 46 
Our understanding of the pathogenesis of spinal muscular atrophy (SMA) remains 47 
incomplete, despite its classification as a single gene disorder and a major genetic cause of 48 
infant mortality. The ubiquitously expressed Survival Motor Neurone protein (SMN) – 49 
named due to the predominant motor neurone loss seen in SMA (Werdnig, 1891; Hoffmann, 50 
1892) – is produced from two genes in humans, with the majority of full-length protein 51 
produced by the SMN1 gene (Lorson et al., 1999). In SMA, an autosomal recessive disease, 52 
mutations in the SMN1 gene leave the SMN2 gene alone to produce small amounts of full-53 
length, functional SMN protein (Lefebvre et al., 1995). This is sufficient to prevent 54 
embryonic lethality but results in the pathology of SMA.   55 
 56 
SMA is primarily characterised by loss of ⍺-motor neurones in the spinal cord, causing 57 
denervation and resulting atrophy of skeletal muscle (Lunn and Wang, 2008; Powis et al., 58 
2016a). However, a range of non-neuromuscular pathologies are also now apparent 59 
(reviewed in: Hamilton and Gillingwater, 2013; Shababi et al., 2014; Nash et al., 2016), 60 
including abnormalities affecting the liver (Vitte et al., 2004; Szunyogova et al., 2016), lung 61 
(Schreml et al., 2012), pancreas (Bowerman et al., 2012; Bowerman et al., 2014), spleen 62 
(Thomson et al., 2016; Deguise et al., 2017; Khairallah et al., 2017), testis (Ottesen et al., 63 
2016), intestines (Sintusek et al., 2016) and the vascular system (Shababi et al., 2012; 64 
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Somers et al., 2012; Sintusek et al., 2016; Somers et al., 2016). Amongst these, cardiac 65 
abnormalities were first putatively described in SMA patients ~60 years ago (Sterne and 66 
Lavieuville, 1964; Gardner-Medwin et al., 1967), but are only now becoming accepted as a 67 
potentially core aspect of SMA, particularly in severe forms of the disease (Wijngaarde et 68 
al., 2017).  69 
 70 
In patients, cardiac defects have been described across mild and severe forms of SMA, 71 
commonly falling into two major categories: structural defects and arrhythmias. Congenital 72 
heart defects, including atrial septal defects, ventricular septal defects and hypoplastic 73 
aortic arch, are the most common structural defects observed in SMA patients (Møller et al., 74 
1990; Burglen et al., 1995; Mulleners et al., 1996; Jong et al., 1998; El-Matary et al., 2004; 75 
Cook et al., 2006; Sarnat and Trevenen et al., 2007; Vaidla et al., 2007; Menke et al., 2008; 76 
Araujo et al., 2009; Grotto et al., 2016; Krupickova et al., 2017). However, pulmonary 77 
hypertension, ventricular enlargement, systolic murmurs and cardiomyopathies have also 78 
been reported (Tanaka et al., 1976; Tanaka et al., 1977; Kimura et al., 1980; Møller et al., 79 
1990; Distefano et al., 1994; Elkohen et al., 1996; Finsterer et al., 1999; El-Matary et al., 80 
2004; Collado-Ortiz et al., 2007; Vaidla et al., 2007; Menke et al., 2008; Kuru et al., 2009). In 81 
the case of arrhythmias, bradycardias are most predominant in children with SMA, although 82 
heart block and ECG tremors have also been noted (Tanaka et al., 1976; Kimura et al., 1980; 83 
Dawood and Moosa, 1983; Coletta et al., 1989; Finsterer et al., 1999; Arai et al., 2005; 84 
Hachiya et al., 2005; Takahashi et al., 2006; Rudnik-Schöneborn et al., 2008; Roos et al., 85 
2009; Haliloglu et al., 2015; Grotto et al., 2016). Together these findings do not immediately 86 
suggest a common or consistent aetiology. Therefore, further work is required to 87 
understand the degree to which these represent primary or secondary causative co-88 
morbidities.  89 
 90 
Heart defects have been reliably reproduced in both severe and mild mouse models of SMA. 91 
These include; structural changes represented by thinning of the interventricular septum 92 
(IVS) and left ventricular (LV) wall (Bogdanik et al., 2015; Schreml et al., 2013; Shababi et al., 93 
2010); dilated cardiomyopathy (Bevan et al., 2010; Heier et al., 2010; Schreml et al., 2013; 94 
Bogdanik et al., 2015); and increased fibrosis and oxidative stress (Shababi et al., 2010). In 95 
both severe and mild mouse models, reports of both a decreased ejection fraction (Bevan et 96 
al., 2010; Bogdanik et al., 2015) and arrhythmias, particularly bradycardia (Bevan et al., 97 
2010; Heier et al., 2010; Shababi et al., 2010; Biondi et al., 2012; Bogdanik et al., 2015), 98 
indicate functional changes.  Significantly, in the very mild ‘Burgheron’ mouse model, some 99 
mice die from severe cardiomyopathy rather than the effects of neuromuscular pathology 100 
(Bogdanik et al., 2015). However, our understanding of these heart defects is still 101 
incomplete.  102 
 103 
Heart defects in SMA represent only one aspect of disruption to the cardiovascular system. 104 
Other notable changes include a pronounced decrease in blood vessel density in skeletal 105 
muscle of both patients and a severe mouse model (Somers et al., 2012; Somers et al., 106 
2016), and in the spinal cord (Somers et al., 2016), intestines (Sintusek et al., 2016) and 107 
heart (Shababi et al., 2012) of severe SMA mouse models. Distal necrosis is seen in the 108 
fingers and toes of patients (Araujo et al., 2009; Rudnik-Schöneborn et al., 2010), and in the 109 
ears and tail of mouse models (Hsieh-Li et al., 2000; Tsai et al., 2006; Narver et al., 2008; 110 
Hua et al., 2010; Riessland et al., 2010; Schreml et al., 2013; Bogdanik et al., 2015; Catapano 111 
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et al., 2016). This necrosis in patients is resolved by anticoagulant treatment, suggesting 112 
that these are thrombotic occlusions (Araujo et al., 2009). Finally, there is consistent 113 
evidence of persistent extramedullary haematopoiesis in SMA. In a severe mouse model, 114 
the liver is undergoing erythropoiesis; it has an increased number of megakaryocytes; 115 
elevated platelet levels; and higher levels of normoblasts (nucleated red blood cells) in 116 
blood samples (Szunyogova et al., 2016). Similarly, the spleen of a severe SMA mouse also 117 
has increased megakaryocyte density and immature architecture indicative of ongoing 118 
haematopoiesis (Thomson et al., 2016). Abnormalities of the spleen have also been 119 
reported in SMA patients, with red pulp congestion and the presence of erythroid 120 
precursors (Thomson et al., 2016).  121 
 122 
Given the growing awareness of cardiovascular defects in SMA, we set out to undertake a 123 
detailed morphological assessment of the heart in the ‘Taiwanese’ mouse model of severe 124 
SMA. By focussing on the period between birth and the first appearance of overt 125 
neuromuscular symptoms, we attempted to identify the initiation of cardiovascular defects, 126 
giving a better understanding of mechanisms underlying these phenotypes in SMA.   127 
 128 
We report significant structural and molecular defects in the heart, prior to, or in tandem 129 
with overt neuromuscular pathology; key molecular targets of SMN-depletion in the heart; 130 
and suggest a multifactorial cardiovascular system pathology.  131 
 132 
Methods 133 
 134 
Mice 135 
 136 
The Taiwanese SMA mouse model on a congenic FVB background was used to replicate a 137 
severe phenotype of SMA. Taiwanese SMA mice were maintained as breeding pairs under 138 
standard specific-pathogen-free conditions in animal care facilities at Edinburgh University 139 
(Hsieh-Li et al., 2000; Riessland et al., 2010; Powis et al., 2016b). Offspring littermates were 140 
either heterozygous for Smn knockout (Smn
+/-
;SMN2
tg/0
) and used as controls, or 141 
homozygous (Smn
-/-
;SMN2
tg/0
) and used as SMA disease model. All experimental protocols 142 
were approved by Edinburgh University internal research and ethics committees and were 143 
carried out in accordance with licenses obtained from the United Kingdom Home Office 144 
under the Animals (Scientific Procedures) Act 1986. Genotyping of mice was carried out via 145 
standard PCR protocols (Wishart et al., 2014). Day of birth is defined as postnatal day 1 (P1). 146 
 147 
Tissue Processing 148 
 149 
Hearts were harvested between P1-P8 from mice sacrificed by intraperitoneal injection of 150 
sodium pentobarbital in accordance with UK guidance and rules for the use of animals in 151 
research. Hearts were then fixed for 4hrs in 4 % paraformaldehyde (PFA) before undergoing 152 
cryoprotection in 30 % sucrose and embedding in OCT. Hearts were cryo-sectioned at a 153 
thickness of 7 μm. Sections then underwent either basic haematoxylin and eosin (H&E) 154 
staining or immunohistochemistry. 155 
 156 
Immunohistochemisty 157 
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 158 
Heart sections were incubated overnight at 4 °C with the following primary antibodies: 159 
rabbit polyclonal anti-Collagen IV (Millipore, AB756P), rabbit polyclonal anti-Ki67 (Abcam, 160 
ab16667) and rat monoclonal anti-Ly76 (Abcam, ab91113); and for 2 hours with the 161 
corresponding secondary antibodies: Cy3 Goat anti-rabbit IgG (H+L) (Life Technologies, A-162 
10520) and Cy3 goat anti-rat IgG (H+L) (Life Technologies, A-10522). 3x10 minute washes in 163 
PBT (0.1M PBS with 0.1 % Tween-20) and 0.1 M PBS were carried out between and after 164 
antibody incubation. Rhodamine labelled Griffonia Lectin 1 (GSL-1) was used to stain 165 
vasculature. Sections were coverslipped using mowiol mounting media (10% Mowiol 166 
(Sigma-Aldrich, 81381), 20 % Glycerol, 50 % 0.2 M Tris buffer pH 8.5, 3 % 1,4-167 
diazobicyclooctane made up in distilled water) containing DAPI. Sections were imaged using 168 
Nikon eclipse e400 microscope (10x objective) and its images captured using QICAM Fast 169 
1394 camera and Improvision Velocity 4 image capture software. 170 
 171 
Quantitative Western Blotting 172 
 173 
Quantitative Western blotting was carried out on 3 hearts per genotype (Eaton et al., 2014). 174 
Briefly, hearts were digested in RIPA buffer containing 2.5 % Halt protease inhibitor cocktail 175 
and homogenised. BCA assay was carried out to quantify protein concentration of individual 176 
samples. 15 μg of protein was loaded per well. Samples were separated by electrophoresis 177 
on precast Bolt
TM
 4-12 % Bis-Tris Plus Gels (NW04120BOX) and then transferred to 178 
nitrocellulose membranes using semi-dry I-Blot
® 
transfer system (Invitrogen,
 
UK). Reversible 179 
total protein stain was carried out using Li-COR Revert total protein stain and wash solution 180 
(LI-COR, 926-11011). To revert the membrane 0.1 % sodium hydroxide in 30 % methanol in 181 
water was used. Membranes were incubated overnight at 4 
o
C with the following primary 182 
antibodies: rabbit polyclonal anti-caspase-3 (Abcam, ab13847), rabbit polyclonal anti-183 
angiotensin II receptor 1 (AT-1) (Abcam, ab18801) and goat polyclonal anti-platelet 184 
endothelial cell adhesion molecule-1 (PECAM-1) (R&D Systems, AF3628); diluted in SeaBlock 185 
blocking buffer (ThermoFisher Scientific, 37527) with Tween-20. Corresponding secondary 186 
antibodies, donkey anti-rabbit Alexa Fluor
®
 680 IgG (H+L) (Abcam, ab186692) and donkey 187 
anti-goat Alexa Fluor
®
 790 IgG (H+L) (Abcam, ab175784), were incubated at room 188 
temperature for 2 hours. 6x10 minute washes with 0.1 M PBS were carried out between and 189 
after antibody incubation. Membranes were imaged using Li-COR Odyssey Scanner and 190 
Software. Due to alterations in the expression levels of many standard loading control 191 
proteins in SMA tissues, total protein was used to normalise protein expression (Eaton et al., 192 
2013). Image Studio Lite was used for quantification of Western blots. 193 
 194 
Heart Quantification  195 
 196 
In all analyses, folded or damaged heart sections were rejected. ImageJ was used to 197 
measure the area of the heart and ventricles, for cell counts, and for red blood cell density 198 
analysis. A protractor generated in Adobe Photoshop was used to quantify IVS and LV walls.  199 
 200 
Quantification of Structural Changes to the Heart: IVS width, LV wall width and ventricular 201 
lumen area were measured from 4 H&E stained slides, containing ~8 heart sections per 202 
heart (~30 in total per heart), from the same relative area, i.e. between the apex and the 203 
atrioventricular septum. Images were captured at 40x magnification and under the same 204 
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exposure. The freehand selection tool in Image J was used to measure the area of the heart 205 
and the left and right ventricles in calibrated images. In Adobe Photoshop, to measure the 206 
IVS and the LV wall, the largest rectangle of best fit was placed in the LV and the centre was 207 
found. From here, lines of 20
o
 were drawn radially to intersect the IVS or LV wall and the 208 
ruler tool was used to measure between points on these lines. Distance was either 209 
measured between the edge of the two ventricles for IVS width or between the left 210 
ventricle wall and the edge of the heart for LV wall width. 211 
 212 
Ly76 Density Quantification: The density of Ly76 positive cells was measured from ~8 213 
sections taken from the same relative area in each heart. Images were captured at 40x 214 
magnification and under the same exposure. Brightness and contrast were enhanced in 215 
Adobe Photoshop. The enhanced images were then converted into binary in ImageJ, where 216 
Ly76 positive cells were assigned black, and the background white. A ratio of black to white 217 
pixels for the whole heart area could then be calculated, allowing a relative value for Ly76 218 
positive cell area relative to heart area, expressed as a percentage.  219 
 220 
Cell Density and Ki67 Positive Cell Quantification: Cell density was calculated from ~8 221 
sections at the same relative area in each heart. From each heart section 6 different images 222 
at 400x magnification were captured fully composed of tissue at the same exposure, from 223 
the same 6 areas for each heart, i.e. in the LV wall, the IVS and the RV wall.  DAPI-blue 224 
channels and Ki67-red channels were merged in Adobe Photoshop. ImageJ was then used to 225 
count the number of DAPI positive nuclei only, and both DAPI and Ki67 positive nuclei 226 
combined in the field of view. The number of Ki67 and DAPI positive cells combined was 227 
expressed as a percentage of total number of DAPI positive cells.  228 
 229 
Statistics: All experimental groups consisted of a minimum of 3 different animals, which has 230 
previously shown to be sufficient to attain statistical significance (Szunyogova et al., 2016). 231 
All graphs are shown as mean ± SEM. Unpaired two-tailed t-test and two-way ANOVA were 232 
carried out using PRISM, where * < p0.05; ** < p0.01; *** < p0.001.  233 
 234 
Results 235 
 236 
Gross Heart Morphology is Altered in SMA Mice 237 
 238 
Initial assessment of hearts from SMA mice revealed no obvious gross anatomical 239 
disorganisation across all ages studied from P1 and P3 (pre-symptomatic), through P5 (early 240 
symptomatic) and P8 (symptomatic), but SMA hearts were smaller when compared to 241 
control (Fig. 1A). When heart weight was expressed relative to body weight (which is lower 242 
in late symptomatic SMA mice; see Powis et al., 2016b), there was no significant difference 243 
between SMA and control hearts at any of the ages examined (P1,3,5,8: ns > 0.05: Fig. 1B).  244 
Upon closer observation of transverse sections of the heart stained with H&E, SMA hearts 245 
appeared to have thinner ventricular walls, and larger ventricles, which were congested 246 
with blood (Fig. 1C). IVS and LV wall measurements have been made previously (Bevan et 247 
al., 2010; Shababi et al., 2010), however, the time course of ventricle dilation has not been 248 
analysed. Quantification revealed that the relative area of the heart comprised of the 249 
ventricles was significantly greater in SMA, at pre (P3) and early (P5) -symptomatic ages 250 
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suggesting enlargement of the ventricles occurs early in the SMA phenotype (P1: ns > 0.05; 251 
P3: *** <0.001; P5: * < 0.05) (Fig. 1D). Furthermore, the IVS and LV wall, which together 252 
comprise the main muscle mass of the heart, were thinner, relative to body weight, in SMA 253 
hearts from an early age (Fig. 1E and 1F). The IVS was significantly thinner at pre and early-254 
symptomatic ages (P1: ns > 0.05; P3: * < 0.05; P5: ** < 0.01), whereas the LV wall was 255 
significantly thinner from birth onwards (P1: * < 0.05; P3: *** < 0.001; P5: * < 0.05).  256 
 257 
These data not only show significant changes in the heart wall and IVS in the Taiwanese 258 
SMA mouse model, but moreover indicate that they develop in pre-symptomatic animals, 259 
with evidence of cardiac defects present at birth. This suggests that heart pathology is likely 260 
to represent a primary event in SMA, and is not simply a secondary consequence of 261 
neuromuscular pathology.  262 
 263 
Cardiomyocytes are Disorganised in the SMA Heart 264 
 265 
Given the gross pathology evident in the heart wall of SMA mice, we next investigated the 266 
fine structure of the heart to determine the likely aetiology of the defects in the IVS and LV 267 
wall. To determine the arrangement of cardiomyocytes, collagen IV immunohistochemistry 268 
was used to highlight surrounding basement membranes from birth to early-symptomatic 269 
ages (P1, P3 and P5). The basement membrane surrounds the cardiomyocytes providing 270 
structural support and is important during heart development for the formation of 271 
sarcomeres.  272 
 273 
At P5 the LV wall in control hearts was clearly formed by 3 layers of cardiac muscle; 274 
superficial oblique, cylindrical middle, and deep longitudinal layers (Fig. 2A v and 2B i). The 275 
middle layer in particular was most pronounced, containing strands of cardiomyocytes 276 
which spiralled out anti-clockwise from the LV, twisting in the orientation of heart 277 
contraction (Greenbaum et al., 1981; Sedmera and McQuinn, 2009). This structure not only 278 
ensures a coherent electrical impulse transfer, but is essential for the twisting motion of the 279 
ventricles observed during contraction of the heart. At birth, this spiral structure 280 
surrounding the LV was beginning to develop in the control heart (Fig. 2A i). In contrast, the 281 
heart wall in SMA was disorganised with no apparent development of cardiomyocyte 282 
orientation between birth and P5 (Fig. 2A ii, 2A iv, 2A vi and 2B ii). The appearance was in 283 
fact similar to an embryonic heart, where muscle is arranged circumferentially around the 284 
ventricle rather than radiating from it (Sedmera and McQuinn, 2009). 285 
 286 
During embryonic development trabeculations are formed in the ventricles prior to the 287 
formation of the coronary vasculature to increase surface area for nutrient uptake (Sedmera 288 
et al., 2000). An essential stage in increasing the mass of the compact muscular wall of the 289 
heart is compaction of these trabeculae, which coincides with the formation of the coronary 290 
blood supply (Sedmera et al., 2000). In the control heart, nearer the luminal wall of the LV, 291 
trabeculations can often be seen. These trabeculations are sparse, do not penetrate far into 292 
the lumen, and appear large enough to allow the growth of a blood supply to these cells 293 
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(Fig. 2B iii). In SMA, these trabeculations were greater in number, projected further into the 294 
lumen, and were very thin, with little capacity for a blood supply to invade (Fig. 2B iv). This 295 
occured from birth, where P1 SMA hearts had little definition between the compact wall 296 
and the ventricles (Fig. 2A ii) and was still present at early-symptomatic (P5) ages (Fig. 2A vi).  297 
 298 
Collagen IV immunostaining, used to visualise cardiomyocyte arrangement, showed a non-299 
uniform pattern of labelling with an apparent decrease in staining, particularly towards the 300 
superficial surface in the SMA hearts compared to control hearts. This suggests a defect in 301 
the basement membrane, of which collagen IV is a key component and which is essential to 302 
maintain the organisation of cardiomyocytes in the heart. Further, a significant global 303 
decrease in collagen IV expression in SMA hearts was demonstrated by quantitative 304 
Western blotting at birth (P1: *<0.05) (Fig. 2C). Importantly, collagen IV interacts directly 305 
with SMN protein (Fuller et al., 2016), suggesting a potential mechanistic link between SMN 306 
depletion and heart wall disorganisation.  307 
 308 
SMA Hearts Have a Decreased Number of Cardiomyocytes Associated with Increased 309 
Apoptosis  310 
 311 
To establish the cellular basis of the changes in SMA heart structure, cardiomyocytes were 312 
specifically investigated from birth (P1) through to early-symptomatic ages (P5). SMA hearts 313 
showed a significant decrease in cardiomyocyte number per unit area (density) at pre- (P3) 314 
and early- (P5) symptomatic ages but not at birth (P1: ns > 0.05; P3: **<0.01; P5: ***< 315 
0.001) (Fig 3B). To establish the nature of this decrease in cardiomyocyte density, cell 316 
proliferation and apoptosis were analysed.  Heart sections were stained with Ki67 (Fig. 3A), 317 
a proliferation marker expressed during all phases of division (Scholzen and Gerdes, 2000), 318 
however, no significant difference in the number of proliferating cells between control and 319 
SMA was observed between birth and P5 (P1: ns > 0.05; P3: ns > 0.05; P5: ns > 0.05) (Fig 3C). 320 
Apoptosis was analysed by Western blot for caspase-3, involved in the activation cascade of 321 
caspases responsible for apoptosis execution (Porter and Jänicke, 1999), which showed a 322 
significant increase in early-symptomatic SMA hearts (P1: ns > 0.05; P3: ns > 0.05; P5: **< 323 
0.01) (Fig. 3D). This suggests that the decrease in cardiomyocyte density may be linked to an 324 
increase in cell death consistent with atrophy of the heart.  325 
 326 
Oxidative Stress is Present in SMA Hearts  327 
 328 
Increased apoptosis in cardiomyocytes was investigated further by examining a common 329 
trigger: oxidative stress, which is present in Δ7 SMA mice exhibiting a neuromuscular 330 
phenotype (Shababi et al., 2010). We analysed angiotensin II receptor 1 (AT1) levels as a 331 
marker of oxidative stress in the heart, as this increases ROS by elevating the activity of 332 
NADPH oxidase during heart failure (Qin et al., 2005). Immunohistochemistry showed 333 
dramatically increased amounts of AT-1 in the SMA heart at birth compared to the control 334 
heart (Fig4A). Western blot analyses confirmed these higher levels of AT-1 in SMA compared 335 
to control hearts at both P3 and P5 (P1: ns > 0.05; P3: *< 0.05; P5: ** < 0.01) (Fig. 4A), 336 
indicating the presence of oxidative stress in SMA hearts with onset at a pre-symptomatic 337 
age. 338 
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To substantiate this finding we looked for evidence of mitochondrial-derived oxidative 340 
stress as multiple proteins in the mitochondria are associated with increased ROS 341 
production (Martínez-Reyes and Cuezva, 2014). This includes the ATP synthase complex, 342 
which interacts directly with SMN (Fuller et al., 2016). We analysed levels of subunit 6 of the 343 
ATP synthase complex as mutations or overexpression of this subunit are particularly 344 
associated with oxidative stress (Manczak et al., 2005; Jonckheere et al., 2012). Western 345 
blot analyses showed significantly higher levels of MT-ATP6 in SMA at birth compared to 346 
controls (P1: *<0.05) (Fig. 4B).  347 
The presence of increased oxidative stress at birth not only suggests this is an important 348 
event in the aetiology of SMA heart pathology, but is also indicative of early mitochondrial 349 
dysfunction. As oxidative stress is present prior to increased caspase-3 expression, and 350 
significantly occurs prior to the appearance of neuromuscular symptoms, it is likely to 351 
precede and contribute to cardiomyocyte apoptosis and heart dysfunction. 352 
 353 
SMA Heart Microvasculature is Significantly Decreased  354 
 355 
A reduction in capillary density has been reported across multiple tissues in SMA patients 356 
and animal models, where it is associated with tissue hypoxia (Somers et al., 2016). 357 
Previously, decreased microvasculature in the heart of the Δ7 SMA mouse model has only 358 
been studied at a late-symptomatic age. Here, microvasculature was analysed at early- and 359 
pre-symptomatic ages to establish if it might contribute to, rather than be a symptom of, 360 
heart pathology. Immunostaining of hearts with GSL-1 endothelial cell marker indicated a 361 
gross decrease in microvasculature density throughout the heart wall particularly at P5 in 362 
SMA (Fig 5A,B). Western blot for a second endothelial cell marker, PECAM-1 as used 363 
previously (Somers et al., 2012; Somers et al., 2016), confirmed a significantly decreased 364 
expression in SMA heart at an early-symptomatic age (P5) (P1: ns > 0.05; P3: ns > 0.05; P5: 365 
*< 0.05) (Fig. 5C). This decrease in heart wall microvasculature was particularly apparent at 366 
high magnification in the wall immediately adjacent to the ventricular lumen (Fig 5B).  This 367 
early contributing factor to cardiac defects, is likely to result in hypoxia of cardiomyocytes, 368 
similar to that seen at P5 in the spinal cord of the SMA mouse, and may exacerbate 369 
increased cell death.  370 
 371 
SMA Hearts are Congested with Blood 372 
 373 
The hearts used in this study were not perfused prior to fixation. Therefore, residual blood 374 
left in the heart after removal is likely a reflection of functional circulatory conditions. In our 375 
initial observations of histologically stained hearts, it was apparent that SMA hearts 376 
contained more blood than the controls (Fig 1C). To further examine this increase, we 377 
stained RBCs with Ly76 (which labels all cells in the erythrocyte lineage including RBCs). Ly76 378 
marker showed that heart chambers viewed in cross-sections of P5 control hearts have only 379 
small amounts of blood, whereas SMA hearts are congested with blood, which is most 380 
apparent in the ventricles (Fig 6A). Quantification of Ly76 stain showed a significant (2-3 381 
fold) increase in the RBCs in SMA hearts at both pre- and early-symptomatic ages compared 382 
to controls (P1: ns > 0.05; P3: *< 0.05; P5: *< 0.05) (Fig 6B). This is consistent with a model 383 
where the structural and molecular defects previously observed impact negatively on heart 384 
function, resulting in blood pooling.  385 
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 387 
Discussion  388 
 389 
Here, we show that Taiwanese SMA mouse hearts have thinner muscular walls, with 390 
disorganised basement membranes and cardiomyocytes present pre-symptomatically. 391 
Cardiomyocytes were decreased in density, likely due to increased apoptosis, at an early-392 
symptomatic age; which is associated with increased oxidative stress from birth, and also 393 
decreased microvasculature in the heart at an early symptomatic age. This demonstrates 394 
that heart defects are an early and important feature of disease pathogenesis in SMA.  395 
 396 
The decrease in IVS and LV wall width described here is consistent with findings from other 397 
mouse models, and may be linked to congenital heart defects such as septal defects 398 
between both atria and ventricles in SMA patients. IVS thinning was present from 3 days 399 
postnatally, suggesting a failure to adapt to the radical pressure changes that occur after 400 
birth (Rein et al., 1987). LV wall thinning was observed pre-symptomatically at birth, likely 401 
affecting heart function and therefore systemic blood flow. Taken together, these findings 402 
point toward impaired development of the SMA heart as a significant contributor to 403 
cardiovascular defects.  404 
 405 
Enlarged ventricles contribute to heart dysfunction in SMA hearts 406 
Enlargement of the ventricles is commonly linked to dilation and dysfunction of the heart, 407 
particularly in combination with thinning of the heart walls (Redfield et al., 2003). This is 408 
consistent with the cardiac phenotype described here in SMA, where dilation of the 409 
ventricles is a secondary event, occurring at P3 after the primary event of a decrease in LV 410 
wall width at P1. This dilation phenotype correlates with previous studies showing a 411 
decreased ejection fraction in mouse SMA hearts (Bevan et al., 2010; Bogdanik et al., 2015), 412 
and with cardiac defects, including dilation of atria and ventricles, diastolic dysfunction and 413 
ventricular overload seen in SMA patients (Collado-Oritz et al., 2007; Tanaka et al., 1976; 414 
Kimura et al., 1980; Distefano et al., 1994; Elkohen et al., 1996; Finsterer et al., 1999; Menke 415 
et al., 2008; Kuru et al., 2009; Grotto et al., 2016). Taken together, thinning of the walls and 416 
enlargement of the ventricles in the SMA heart is strikingly similar to dilated 417 
cardiomyopathy (DCM), where the heart becomes enlarged and cannot pump blood 418 
efficiently, evidenced by blood pooling. These defects will likely result in systolic heart 419 
failure (Maron et al., 2006), which has been reported in some SMA patients (Collado-Oritz et 420 
al., 2007). 421 
 422 
Cardiomyocytes are disorganised in SMA hearts 423 
Our findings suggest that gross abnormalities in the SMA heart are underpinned by cellular 424 
defects, likely driven by SMN depletion in the cardiomyocytes. Collagen IV levels were 425 
decreased in SMA, likely affecting cardiomyocyte organisation through its role in basement 426 
membrane structure (Lundgren et al., 1988). The basement membrane maintains 427 
cardiomyocyte shape (Lundgren et al., 1988); anchors them to the ECM (Zellner et al., 428 
1991); regulates their electrical properties (Frank et al., 1977; Yang et al., 2014); regulates 429 
sarcomeric formation and remodelling (Ross and Borg, 2001; Yang et al., 2015) and 430 
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influences force production (Factor and Robinson, 1988; Yang et al., 2015). Specifically, the 431 
collagen IV network increases rigidity and strength resulting in a more fluid and powerful 432 
contraction (Bruggink et al., 2007).  433 
This defective basement membrane and abnormal organisation of cardiomyocytes will likely 434 
impair electrical conduction through end to end gap junctions (Zellner et al., 1991), 435 
preventing a coherent contraction to flow through the heart (Greenbaum et al., 1981; 436 
Sedmera and McQuinn, 2009). In addition, trabeculae are more common in SMA hearts and 437 
the cardiac muscle is circumferentially rather than spirally oriented, both of which suggest 438 
that the heart wall is not maturing correctly in the embryonic period. Compaction of 439 
trabeculae contributes to the thickness of the ventricular and IVS muscular mass, the 440 
papillary muscles, vasculature and the conduction system (Sedmera et al., 2000). The failed 441 
compaction seen in the SMA heart may underlie septal defects and arrhythmias seen in SMA 442 
patients.  443 
 444 
Oxidative stress is present in SMA hearts 445 
In parallel with the structural defects described above, the pre-symptomatic increases in AT-446 
1 and MT-ATP6 reported here suggest that oxidative stress is present in the SMA heart, and 447 
that it precedes increased cardiomyocyte death. Oxidative stress is thought to be critical for 448 
the activation of apoptosis, including caspase activation, in failing hearts (Cesselli et al., 449 
2001). AT-1 is also increased in the heart of the Δ7 SMA mouse model (Shababi et al., 2010), 450 
which points to oxidative stress as a common mechanism in SMA cardiovascular pathology. 451 
In our study caspase levels do not correlate perfectly with cardiomyocyte density, which is 452 
likely due to the high variability in proliferation of cardiomyocytes, particularly at P3, 453 
contributing to the decrease in cell number prior to the increase in cell death. 454 
 455 
As ATP synthase subunits interact directly with SMN protein, and are overexpressed in the 456 
CNS of multiple SMA models, there is a potentially direct mechanistic link between SMN 457 
depletion and cardiac dysfunction (Fuller et al. 2016). Taken further, defects in 458 
mitochondria, including fragmentation of the mitochondrial network, impaired 459 
mitochondrial membrane potential and increased oxidative stress are all thought to be 460 
associated with motor neurone cell death in SMA (Acsadi et al., 2009; Ripolone et al., 2015; 461 
Miller et al., 2016; Xu et al., 2016; Boyd et al., 2017). Cardiomyocytes contain many 462 
mitochondria (more than skeletal muscle) to support their high-energy demands (Hom and 463 
Sheu, 2009), and are therefore highly susceptible to mitochondrial dysfunction-mediated 464 
oxidative stress. Swollen and degenerating mitochondria are seen in cardiomyocytes in late-465 
symptomatic SMNΔ7 mice (Bevan et al., 2010), which is consistent with late-stage heart 466 
failure. Here, however, we show that the changes in the level of a mitochondrial specific 467 
protein, MT-ATP6 are already present at birth suggesting that mitochondrial dysfunction 468 
may be a primary driver of cardiac defects in SMA.  469 
 470 
Blood pools in the ventricls of SMA hearts 471 
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The thin heart walls in SMA are likely to contract less efficiently, resulting in a decreased 472 
ejection fraction (Bevan et al., 2010; Bogdanik et al., 2015), blood pooling (Ghio et al., 473 
2001), additional stress, increased cell death and a positive feedback loop ultimately leading 474 
to heart failure (Narula et al., 1996). However, the heart is a dynamic organ and abnormal 475 
blood flow through the heart, altered by forces including preload and afterload (Bugge-476 
Asperheim and Kiil, 1973), could also contribute to blood pooling. In addition, extrinsic 477 
factors such as altered blood composition, including that resulting from abnormal 478 
erythropoiesis and platelet production in the SMA liver (Szunyogova et al., 2016), will 479 
impact on blood flow and contribute to ventricular distension. These alterations in blood 480 
flow and observations of blood pooling could also explain the pulmonary hypertension and 481 
pulmonary effusion reported in SMA patients (Møller et al., 1990; Distefano et al., 1994; El-482 
Matary et al., 2004; Menke et al., 2008). Here (see Fig. 7), we propose a model to interpret 483 
the cardiac defects observed.  484 
 485 
With a new treatment for SMA, Spinraza (Nusinersen), approved by the FDA and EMA, it is 486 
now critically important to understand these cardiovascular pathologies. The drug is 487 
administered intrathecally, and therefore only targets the central nervous system (Hoy et 488 
al., 2017), which appears to limit its utility in disease treatment (Finkel et al., 2017). 489 
Conversely, an as yet unapproved, systemically-administered gene therapy, may offer hope 490 
of obtaining significant patient benefit (Mendell et al, 2017), by treating the disease as a 491 
whole. Consequently, it is an unfortunate possibility that cardiovascular defects may be 492 
uncovered in these treated SMA patients.  493 
 494 
Conclusion  495 
 496 
In conclusion, the severe Taiwanese SMA mouse model has severe cardiac defects from 497 
birth. Thinning of the IVS and dilation of ventricular lumens was seen from pre-symptomatic 498 
ages through until late symptomatic stages of disease. But most significantly, changes in the 499 
LV width were observed from birth, prior to motor neurone pathology. There were also 500 
changes in the organisation of cardiomyocytes from birth in SMA, which may be linked to 501 
altered levels of basement membrane protein collagen IV; increased oxidative stress in 502 
cardiomyocytes pre-symptomatically; increased apoptosis of cardiomyocytes seen at early-503 
symptomatic ages; decreased microvasculature also at an early symptomatic age; and increased 504 
blood pooling within the SMA heart ventricles at a pre-symptomatic age. This combines to 505 
suggest a phenotype similar to dilated cardiomyopathy that will most likely lead to heart 506 
failure. It is therefore essential to develop systemic therapies for SMA capable of treating 507 
these cardiac pathologies, in addition to the well-established neuromuscular defects. 508 
  509 
Page 12 of 34Journal of Anatomy
For Peer Review Only
Acknowledgements 510 
 511 
We would like to acknowledge the Microscopy and Histology Core Facility at the University 512 
of Aberdeen, Kevin Mackenzie, Debbie Wilkinson, Gillian Milne and Lucy Wight, for the use 513 
of their facilities.  514 
GKM was funded by a research award from RGA awarded to SHP.  515 
ES was funded by a University of Aberdeen Elphinstone PhD Studentship and a research 516 
award from the Euan Macdonald Centre for Motor Neurone Disease Research.  517 
HKS was funded by a Euan Macdonald Centre for Motor Neurone Disease Research PhD 518 
Studentship.  519 
SHP is funded by Tenovus (Scotland), SMA Trust and Prinses Beatrix Spierfonds.  520 
THG is funded by SMA Trust (UK SMA Research Consortium Award), Muscular Dystrophy UK, 521 
and Anatomical Society (PhD Studentship).   522 
Page 13 of 34 Journal of Anatomy
For Peer Review Only
Conflict of Interest 523 
 524 
Please note that SHP is a member of the JoA Editorial Board and THG is joint EiC of JoA. 525 
Page 14 of 34Journal of Anatomy
For Peer Review Only
Author Contributions 526 
 527 
SHP, THG, GKM and ES designed the study 528 
GKM, ES and HKS carried out the experiments 529 
GKM analysed the data 530 
SHP, THG, GKM, ES and HKS prepared the manuscript  531 
Page 15 of 34 Journal of Anatomy
For Peer Review Only
References 532 
 533 
Acsadi, G., Lee, I., Li, X., Khaidakov, M., Pecinova, A., Parker, G. and Hüttemann, M. (2009). 534 
Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. Journal of 535 
Neuroscience Research, 87(12), 2748-2756. 536 
Adachi, S., Ito, H., Tamamori-Adachi, M., Ono, Y., Nozato, T., Abe, S., Ikeda, M., Marumo, F. 537 
and Hiroe, M. (2001). Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in 538 
cardiomyocytes. Circulation Reseasrch, 89(4), 408-414. 539 
Arai, H., Tanabe, Y., Hachiya, Y., Otsuka, E., Kumada, S., Furushima, W., Kohyama, J., 540 
Yamashita, S., Takanashi, J. and Kohno, Y. (2005). Finger cold-induced vasodilation, 541 
sympathetic skin response and R-R interval variation in patients with progressive spinal 542 
muscular atrophy. Journal of Child Neurology, 20(11), 871-875. 543 
Araujo, A., Araujo, M. and Swoboda, K. (2009). Vascular perfusion abnormalities in infants 544 
with spinal muscular atrophy. Journal of Pediatrics, 155(2), 292-294. 545 
Bevan, A., Hutchinson, K., Foust, K., Braun, L., McGovern, V., Schmelzer, L., Ward, J., 546 
Petruska, J., Lucchesi, P., Burghes, A. and Kasper, B. (2010). Early heart failure in the SMN ∆7 547 
model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Human 548 
Molecular Genetics, 19(20), 3895-3905. 549 
Biondi, O., Lopes, P., Desseille, C., Branchu, J., Chali, F., Salah, A., Pariset, C., Chanoine, C. 550 
and Charbonnier, F. (2012). Physical exercise reduces cardiac defects in type 2 spinal 551 
muscular atophy-like mice. Journal of Physiology, 590(22), 5907-5925. 552 
Bogdanik, L., Osborne, M., Davis, C., Martin, W., Austin, A., Rigo, F., Bennett, C. and Lutz, C. 553 
(2015). Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation 554 
delay in a new mouse model for type II/III spinal muscular atrophy. Proceeding of the 555 
National Academy of Sciences of the United States of America, 112(43), 865-872. 556 
Bowerman, M., Michalski, J., Beauvais, A., Murray, L., De Repentigny, Y. and Kothary, R. 557 
(2014). Defects in pancreatic development and glucose metabolism in SMN-depleted mice 558 
independent of canonical spinal muscular atrophy neuromuscular pathology. Human 559 
Molecular Genetics, 23(13), 3432-3444. 560 
Bowerman, M., Swoboda, K., Michalski, J., Wang, G., Reeks, C., Beauvais, A., Murphy, K., 561 
Woulfe, J., Screaton, R., Scott, F. and Kothary, R. (2012). Glucose metabolism and pancreatic 562 
defects in spinal muscular atrophy. Annals of Neurology, 72(2), 256-268. 563 
Boyd, P., Tu, W., Shorrock, H., Groen, E., Carter, R., Powis, R., Thomson, S., Thomson, D., 564 
Graham, L., Motyl, A., Wishart, T., Highley, J., Morton, N., Becker, T., Becker, C., Heath, P. 565 
and Gillingwater, T. (2017). Bioenergetic status modulates motor neuron vulnerability and 566 
Page 16 of 34Journal of Anatomy
For Peer Review Only
pathogenesis in a zebrafish model of spinal muscular atrophy. PLOS Genetics, 13(4), 567 
e1006744. 568 
Bruggink, A., Van Oosterhout, M., De Jonge, N., Cleutjens, J., Van Wichen, D., Van Kuik, J., 569 
Tilanus, M., Gmelig-Meyling, F., Van Den Tweel, J. and De Wenger, R. (2007). Type IV 570 
collagen degradation in the myocardial basement membrane after unloading of the failing 571 
heart by a left ventricular assist device. Laboratory Investigation, 87(11), 1125-1137. 572 
Bugge-Asperheim, B. and Kiil, F. (1973). Preload, contractility, and afterload as determinants 573 
of stroke volume during elevation of aortic blood pressure in dogs. Cardiovascular Research, 574 
7(4), 328-341. 575 
Buja, M. and Entman, M. (1998). Modes of myocardial cell injury and cell death in ischemic 576 
heart disease. Circulation, 98(14), 1355-1357. 577 
Bürglen, L., Spiegel, R., Ignatius, J., Cobben, J., Landrieu, P., Lefebvre, S., Munnich, A. and 578 
Melki, J. (1995). SMN gene deletion in variant of infantile spinal muscular atrophy. The 579 
Lancet, 346(8970), 316-317. 580 
Catapano, F., Zaharieva, I., Scoto, M., Marrosu, E., Morgan, J., Muntoni, F. and Zhou, H. 581 
(2016). Altered levels of microRNA-9, -206, and -132 in spinal muscular atrophy and their 582 
response to antisense oligonucleotide therapy.  Molecular Therapy – Nucleic Acids, 5(7), 583 
e331. 584 
Cesselli, D. Jakoniuk, I., Barlucchi,L., Beltrami, A., Hintze, T., Nadal-Ginard, B., Kajstura, J., 585 
Leri, A. and Anversa, P. (2001). Oxidative stress-mediated cardiac cell death is a major 586 
determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. 587 
Circulation Research, 89(3), 279-286. 588 
 589 
Collado-Ortiz, M., Shkurovich-Bialik, P., González-De Leo, S. ad Arch-Tirado, E. (2007). Type 1 590 
spinal atrophy (Werdnig-Hoffman disease). Case report. Cirugia y Cirujanos, 75(2), 119-122. 591 
Coletta, C., Carboni, P., Carunchio, A., Porro, G. and Bacci, V. (1989). Electrocardiographic 592 
abnormalities in childhood spinal muscular atrophy. International Journal of Cardiology, 593 
24(3), 283-288. 594 
Cook, A., Curzon, C. and Milazzo, A. (2006). An infant with hypoplastic left heart syndrome 595 
and spinal muscular atrophy. Cardiology in the Young, 16(1), 78-80. 596 
Dawood, A. and Moosa, A. (1983). Hand and ECG tremor in spinal muscular atrophy. 597 
Archives of Disease in Childhood, 58(5), 376-378. 598 
Deguise, M., De Repentigny, Y., McFall, E., Auclair, N., Sad, S. and Kothary, R. (2017). 599 
Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy 600 
mice. Human Molecular Genetics, 26(4), 801-819. 601 
Page 17 of 34 Journal of Anatomy
For Peer Review Only
Distefano, G., Sciacca, P., Parisi, M., Parano, E., Smilari, P., Marietta, M. and Fiumara, A. 602 
(1994). Heart involvement in progressive spinal muscular atrophy. A review of the literature 603 
and case histories in childhood. Pediatria Medica Chirurgica, 16(2), 125-128. 604 
Eaton, S., Hurtado, M., Oldknow, K., Graham, L., Marchant, T., Gillingwater, T., Farquharson, 605 
C. and Wishart, T. (2014). A guide to modern quantitative fluorescent western blotting with 606 
troubleshooting strategies. Journal of Visualized Experiments, 93, e52099. 607 
Eaton, S., Roche, S., Hurtado, M., Oldknow, K., Farquharson, C., Gillingwater, T. and Wishart, 608 
T. (2013). Total protein analysis as a reliable loading control for quantitative fluorescent 609 
western blotting. PLOS One, 8(8), e72457. 610 
El-Matary, W., Kotagiri, S., Cameron, D. and Peart, I. (2004). Spinal muscle atrophy type 1 611 
(Werdnig-Hoffman disease) with complex cardiac malformation. European Journal of 612 
Pediatrics, 163(6), 331-332. 613 
Elkohen, M., Vaksmann, G., Elkohen, M., Francart, C., Foucher, C. and Rey, C. (1996). Cardiac 614 
involvement in Kugelberg-Welander disease: A prospective study of 8 cases. Archives des 615 
Maladies du Coeur et des Vaisseaux, 89(5), 611-617. 616 
Factor, S. and Robinson, T. (1988). Comparative connective tissue structure-function 617 
relationships in biological pumps. Lab Investigations, 58(2), 150-156. 618 
Finkel, R., Mercuri, E., Darras, B., Connolly, A., Kuntz, N., Kirschner, J., Chiriboga, C., Saito, K., 619 
Servais, L., Tizzano, E., Topaloglu, H., Tulinius, M., Montes, J., Glanzman, A., Bishop, K., 620 
Zhong, Z., Gheuens, S., Bennett, C., Schneider, E., Farwell, W. and De Vivo, D. (2017). 621 
Nusinersen versus sham control in infantile-onset spinal muscular atrophy. The New 622 
England Journal of Medicine, 377(18), 1723-1732. 623 
Finsterer, J. and Stöllberger, C. (1999) Cardiac involvement in Werdnig-Hoffmann’s spinal 624 
muscular atrophy. Cardiology, 92(3), 178-182. 625 
Frank, J., Langer, G., Nudd, L. and Seraydarian, K. (1977). The myocardial cell surface, its 626 
histochemistry, and the effect of sialic acid and calcium removal on its structure and cellular 627 
ionic exchange. Circulation Research, 41(5), 702-714. 628 
Fuller, H., Gillingwater, T. and Wishart, T. (2016). Commonality amid diversity: Multi-study 629 
proteomic identification of conserved disease mechanisms in spinal muscular atrophy. 630 
Neuromuscular Disorders, 26(9), 560-569. 631 
Gardner-Medwin, D., Hudgson, P. and Walton, J. (1967). Benign spinal muscular atrophy 632 
arising in childhood and adolescence. Journal of the Neurological Sciences, 5(1), 121-158. 633 
Ghio, S., Gavazzi, A., Campana, C., Inserra, C., Klersy, C., Sebastiani, R., Arbustini, E., 634 
Recusani, F. and Tavazzi, L. (2001). Independent and additive prognostic value of right 635 
Page 18 of 34Journal of Anatomy
For Peer Review Only
ventricular systolic function and pulmonary artery pressure in patients with chronic heart 636 
failure. Journal of the American College of Cardiology, 37(1), 183-188. 637 
Gogliotti, R., Quinlan, K., Barlow, C., Heier, C., Heckman, C. and DiDonato, C. (2012). Motor 638 
neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects 639 
are a consequence, not a cause, of motor neuron dysfunction. Journal of Neuroscience, 640 
32(11), 3818-3829. 641 
Greenbaum, R., Ho, S., Gibson, D., Becker, A. and Anderson, R. (1981). Left ventricular fibre 642 
architecture in man. British Heart Journal, 45(3), 248-263. 643 
Grotto, S., Cuisset, J., Marret, S., Drunat, S., Faure, P., Audebert-Bellanger, S., Desguerre, 644 
I., Flurin, V., Grebille, A., Guerrot, A., Journel, H., Morin, G., Plessis, G., Renolleau, S., Roume, 645 
J., Simon-Bouy, B., Touraine, R., Willems, M., Frébourg, T., Verspyck, E., Saugier-Veber, P. 646 
(2016). Type 0 spinal muscular atrophy: Further delineation of prenatal and postnatal 647 
features in 16 patients. Journal of Neuromuscular Diseases, 3(4), 487-495. 648 
Hachiya, Y., Arai, H., Hayashi, M., Kumada, S., Furushima, W., Ohtsuka, E., Ito, Y., Uchiyama, 649 
A. and Kurata, K. (2005). Autonomic dysfunction in cases of spinal muscular atrophy type 1 650 
with long survival. Brain and Development, 27(8), 574-578. 651 
Haliloglu, G., Gungor, M. and Anlar, B. (2015). The role of electrocardiography in the 652 
diagnosis of spinal muscular atrophy type III. The Journal of Pediatrics, 166(4), 1092. 653 
Hamilton, G. and Gillingwater, T. (2013). Spinal muscular atrophy: Going beyond the motor 654 
neuron. Trends in Molecular Medicine, 19(1), 40-50. 655 
 656 
Heier, C., Satta, R., Lutz, C. and Didonato, C. (2010). Arrhythmia and cardiac defects are a 657 
feature of spinal muscular atrophy model mice. Human Molecular Genetics, 19(20), 3906-658 
3918. 659 
Hoffmann, J. (1892). Familial spinal muscular atrophy in infancy. Dtsch Z Nervenheilkd, 3, 660 
427-470. 661 
Hom, J., Sheu, S. (2009). Morphological dynamics of mitochondria – A special emphasis on 662 
cardiac muscle cells. Journal of Molecular and Cellular Cardiology, 46(6), 811-820. 663 
Hoy, S. (2017). Nusinersen: First global approval. Drugs, 77(4), 473-479. 664 
Hsieh-Li, H., Chang, J., Jong, Y., Wu, M., Wang, N., Tsai, C. and Li, H. (2000). A mouse model 665 
for spinal muscular atrophy. Nature Genetics, 24(1), 66-70. 666 
Hua, Y., Liu, Y., Sahashi, K., Rigo, F., Bennett, C. and Krainer, A. (2015) Motor neuron cell-667 
nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe 668 
transgenic mouse models. Genes and Development, 29(3), 288-297.  669 
Page 19 of 34 Journal of Anatomy
For Peer Review Only
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. and Krainer, A. (2011). 670 
Peripheral SMN restoration is essential for long-term rescue of a 671 
severe spinal muscular atrophy mouse model. Nature, 478(7367), 123-126. 672 
Jonckheere, A., Smeitink, J. and Rodenburg, R. (2012). Mitochondrial ATP synthase: 673 
Architecture, function and pathology. Journal of Inherited Metabolic Disease, 35(2), 211-674 
225. 675 
Jong, Y., Chang, J. and Wu, J. (1998). Large-scale deletions in a Chinese infant associated 676 
with a variant form of Werdnig-Hoffmann disease. Neurology, 51(3), 878-879. 677 
Khairallah, M., Astroski, J., Custer, S., Androphy, E., Franklin, C. and Lorson, C. (2017). SMN 678 
deficiency negatively impacts red pulp macrophages and spleen development in mouse 679 
models of spinal muscular atrophy. Human Molecular Genetics, 26(5), 932-941. 680 
Kimura, S., Yokota, H., Tateda, K., Miyamoto, K., Yamamoto, K., Shibata, J. (1980). A case of 681 
the Kugelberg-Welander syndrome complicated with cardiac lesions. Japanese Heart 682 
Journal, 21(3), 417-422. 683 
Krupickova, S., Rigby, M., Jicinska, H., Marais, G., Rubens, M. and Carvalho, J. (2017). Total 684 
anomalous pulmonary venous connection to an unroofed coronary sinus diagnosed in a 685 
fetus with associated spinal muscular atrophy type I. Ultrasound in Obstetrics and 686 
Gynecology, uog. 17432. 687 
Kuru, S., Sakai, M., Konagaya, M., Yoshida, M., Hashizume, Y. and Saito, K. (2009). An 688 
autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease). 689 
Neuropathology, 29(1), 63-67. 690 
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., 691 
Cruaud, C., Millasseau, P., Zeviani, M., Le Paslier, D., Frézal, J., Cohen, D., Weissenbach, J., 692 
Munnich, A. and Melki. (1995). Identification and characterisation of a spinal muscular 693 
atrophy-determining gene. Cell, 80(1), 155-156. 694 
Lorson, C., Hahnen, E., Androphy, E. and Wirth, B. (1999). A single nucleotide in the SMN 695 
gene regulates splicing and is responsible for spinal muscular atrophy. Proceedings of the 696 
National Academy of Sciences, 96(11), 6307-6311.  697 
Lundgren, E., Gullberg, D., Rubin, K., Borg, T., Terracio, M. and Terracio, L. (1988). In vitro 698 
studies on adult cardiac myocytes: Attachment and biosynthesis of collagen IV and laminin. 699 
Journal of Cellular Physiology, 136(1), 43-53. 700 
Lunn, M. and Wang, C. (2008). Spinal muscular atrophy. The Lancet, 371(9630), 2120-2133. 701 
Manczak, M., Jung, Y., Park, B., Partovi, D. and Reddy, P. (2005). Time-course of 702 
mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, 703 
oxidative damage, and cytochrome c in aging. Journal of Neurochemistry, 92(3), 494-504. 704 
Page 20 of 34Journal of Anatomy
For Peer Review Only
 705 
Maron, B., Towbin, J. Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A., Seidman, 706 
C. and Young, J. (2006). An American Heart Association scientific statement from the council 707 
on clinical cardiology, heart failure and transplantation committee; quality of care and 708 
outcomes research and functional genomics and translational biology interdisciplinary 709 
working groups; and council on epidemiology and prevention. Circulation, 113(14), 1807-710 
1816. 711 
Martínez-Reyes, I. and Cuezva, J. (2014). The H
+
-ATP synthase: A gate to ROS-mediated cell 712 
death or cell survival. Biochimica et Biophysica Acta – Bioenergetics, 1837(7), 1099-1112. 713 
Mendell, J., Al-Zaidy, S., Shell, R., Arnold, W., Rodino-Klapac, L., Prior, T., Lowes, L., Alfano, 714 
L., Berry, K., Church, K., Kissel, J., Nagendran, S., L’Italien, J., Sproule, D., Wells, C., Cardenas, 715 
J., Heitzer, M., Kaspar, A., Corcoran, S., Braun, L., Likhite, S., Miranda, C., Meyer, K., Foust, 716 
K., Burghes, A. and Kaspar, B. (2017). Single-dose gene-replacement therapy for spinal 717 
muscular atrophy. The New England Journal of Medicine, 377(18), 1713-1722. 718 
Menke, L., Poll-The, B., Clur, S., Bilardo, C., Van Der Wal, A., Lemmink, H. and Cobben, J. 719 
(2008). Congenital heart defects in spinal muscular atrophy type I: A clinical report of two 720 
siblings and a review of the literature. American Journal of Medical Genetics, Part A, 146(6), 721 
740-744. 722 
Miller, N., Shi, H., Zelikovich, A. and Ma, Y. (2015). Motor neuron mitochondrial dysfunction 723 
in spinal muscular atrophy. Human Molecular Genetics, 25(16), 3395-3406. 724 
Møller, P., Moe, N., Saugstad, O., Skullerud, K., Velken, M., Berg K, Nitter-Hauge, S 725 
and Børresen, A. (1990) Spinal muscular atrophy type 1 combined with atrial septal defect in 726 
three sibs. Clinical Genetics. 38(2), 81-83. 727 
Mulleners, W., Van Ravenswaay, C., Gabreels, F., Hamel, B., Van Oort, A. and Sengers, R. 728 
(1996). Spinal muscular atrophy combined with congenital heart disease: A report of two 729 
cases. Neuropediatrics, 27(6), 333-334. 730 
Narula, J., Haider, N., Virmani, R., Disalvo, T., Kolodgie, F., Hajjar, R., Schmidt, U., Semigran, 731 
M., Dec, G. and Khaw, B. (1996). Apoptosis in myocytes in end-stage heart failure. New 732 
England Journal of Medicine, 335(16), 1182-1189. 733 
Narver, H., Kong, L., Burnett, B., Choe, D., Bosch-Marcé, M., Taye, A., Eckhaus, M. and 734 
Sumner, C. (2008). Sustained improvement of spinal muscular atrophy mice treated with 735 
trichostatin A plus nutrition. Annals of Neurology, 64(4), 465-470. 736 
Nash, L., Burns, J., Chardon, J., Kothary, R. and Parks, R. (2016). Spinal muscular atrophy: 737 
More than a disease of motor neurons? Current Molecular Medicine, 16(9), 779-792. 738 
Page 21 of 34 Journal of Anatomy
For Peer Review Only
Ottesen, E., Howell, M., Singh, N., Seo, J., Whitley, E. and Singh, R. (2016). Severe 739 
impairment of male reproductive organ development in a low SMN expressing mouse 740 
model of spinal muscular atrophy. Scientific Reports, 6, 20193. 741 
Porter, A. and Jänicke, R. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death and 742 
Differentiation, 6(2), 99-104. 743 
Powis, R. and Gillingwater, T. (2016a). Selective loss of alpha motor neurons with sparing of 744 
gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal 745 
muscular atrophy. Journal of Anatomy, 228(3), 443-451. 746 
Powis, R., Karyka, E., Boyd, P., Côme, J., Jones, R., Zheng, Y., Szunyogova, E., Groen, E., 747 
Hunter, G., Thomson, D., Wishart, T., Becker, C., Parson, S., Martinat, C., Azzouz, M. and 748 
Gillingwater, T. (2016b). Systemic restoration of UBA1 ameliorates disease in spinal 749 
muscular atrophy. JCI Insight, 1(11), e87908. 750 
Qin, F., Patel, R., Yan, C. and Weimin, L. (2005). NADPH oxidase is involved in angiotensin II-751 
induced apoptosis in H9C2 cardiac muscle cells: Effects of apocynin. Free Radical Biology 752 
and Medicine, 40(2), 236-246. 753 
Redfield, M., Jacobsen, S., Burnett, J., Mahoney, D., Bailey, K. and Rodeheffer, R. (2003). 754 
Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the 755 
scope of the heat failure epidemic. Journal of the American Medical Association, 289(2), 756 
194-202. 757 
Rein, A., Sanders, S., Colan, S., Parness, I. and Epstein, M. (1987). Left ventricular mechanics 758 
in the normal newborn. Circulation, 76(5), 1029-1036. 759 
Riessland, M., Ackermann, B., Förster, A., Jakubik, M., Hauke, J., Garbes, L., Fritzsche, I., 760 
Mende, Y., Blumcke, I., Hahnen, W. and Wirth, B. (2010). SAHA ameliorates the SMA 761 
phenotype in two mouse models for spinal muscular atrophy. Human Molecular Genetics, 762 
19(8), 1492-1506. 763 
Ripolone, M., Ronchi, D., Violano, R., Vallejo, D., Fagiolari, G., Barca, E., Lucchini, V., 764 
Colombo, I., Villa, L., Berardinelli, A., Balottin, U., Morandi, L., Mora, M., Bordoni, A., 765 
Fortunato, F., Corti, S., Parisi, D., Toscano, A., Sciacco, M., Di Mauro, S.,, Comi, G. and 766 
Moggio, M. (2015). Impaired muscle mitochondrial biogenesis and myogenesis in spinal 767 
muscular atrophy. JAMA Neurology, 72(6), 666-675. 768 
 769 
Roos, M., Sarkozy, A., Chierchia, G., De Wilde, P., Schmedding, E. and Brugada, P. (2009). 770 
Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy 771 
(Kugelberg-Welander disease). Journal of Cardiovascular Electrophysiology, 20(3), 342-344. 772 
 773 
Page 22 of 34Journal of Anatomy
For Peer Review Only
Ross, R. and Borg, T. (2001). Integrins and the myocardium. Circulation Research, 88(11), 774 
1112-1119. 775 
Rudnik-Schöneborn, S., Heller, R., Berg, C., Betzler, C., Grimm, T., Eggermann, T., 776 
Eggermann, K., Wirth, R., Wirth, B. and Zerres, K. (2008). Congenital heart disease is a 777 
feature of severe infantile spinal muscular atrophy. Journal of Medical Genetics, 45(10), 635-778 
638. 779 
Rudnik-Schöneborn, S., Vogelgesang, S., Armbrust, S., Graul-Neumann, L., Fusch, C. and 780 
Zerres, K. (2010). Digital necroses and vascular thrombosis in severe spinal muscular 781 
atrophy. Muscle and Nerve, 42(1), 144-147. 782 
Sarnat, H. and Trevenen, C. (2007). Motor neuron degeneration in a 20-week male fetus: 783 
spinal muscular atrophy type 0. Canadian Journal of Neurological Sciences, 34(2), 215-220. 784 
Scholzen, T. and Gerdes, J. (2000). The Ki-67 protein: From the known and the unknown. 785 
Journal of Cellular Physiology, 182(3), 311-322.  786 
Schreml, J., Riessland, M., Paterno, M., Garbes, L., Roßbach, K., Ackermann, B., Krämer, 787 
J., Somers, E., Parson, S., Heller, R., Berkessel, A., Sterner-Kock, A. and Wirth, B. (2013). 788 
Severe SMA mice show organ impairment that cannot be rescued by therapy with the 789 
HDACi JNJ-26481585. European Journal of Human Genetics, 21(6), 643-652. 790 
Sedmera, D. and McQuinn, T. (2008). Embryogenesis of the heart muscle. Heart Failure 791 
Clinics, 4(3), 235-245. 792 
Sedmera, D., Pexieder, T., Vuillemin, M., Thompson, R. and Anderson, R. (2000). 793 
Developmental patterning of the myocardium. Anatomical Record, 258(4), 319-337. 794 
Shababi, M., Habibi, J., Ma, L., Glascock, J., Sowers, J. and Lorson, C. (2012). Partial 795 
restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. 796 
Journal of Molecular and Cellular Cardiology, 52(5), 1074-1082. 797 
Shababi, M., Habibi, J., Yang, H., Vale, S., Sewell, W. and Lorson, C. (2010). Cardiac defects 798 
contribute to the pathology of spinal muscular atrophy models. Human Molecular Genetics, 799 
19(20), 4059-4071.  800 
Shababi, M., Lorson, C. and Rudnik-Schöneborn, S. (2014). Spinal muscular atrophy: a motor 801 
neuron disorder or a multi-organ disease? Journal of Anatomy, 224(1), 15-28. 802 
 803 
Sintusek, P., Catapano, F., Angkathunkayul, N., Marrosu, E., Parson, S., Morgan, J., Muntoni, 804 
F. and Zhou, H. (2016). Histopathological defects in intestine in severe spinal muscular 805 
atrophy mice are improved by systemic antisense oligonucleotide treatment. PLOS One, 806 
11(5), e0155032. 807 
Page 23 of 34 Journal of Anatomy
For Peer Review Only
Somers, E., Lees, R., Hoban, K., Sleigh, J., Zhou, H., Muntoni, F., Talbot, K., Gillingwater, T. 808 
and Parson, S. (2016). Vascular defects and spinal cord hypoxia in spinal muscular atrophy. 809 
Annals of Neurology, 79(2), 217-230. 810 
Somers, E., Stencel, Z., Wishart, T., Gillingwater, T. and Parson, S. (2012). Density, calibre 811 
and ramification of muscle capillaries are altered in a mouse model of severe spinal 812 
muscular atrophy. Neuromuscular Disorders, 22(5), 435-442.  813 
Sterne, J. and Lavieuville, M. (1964). Cardiac manifestations during diseases of the nervous 814 
and muscular systems. Gazette Médicale de France, 71, 1925-1932. 815 
Szunyogova, E., Zhou, H., Maxwell, G., Powis, R., Muntoni, F., Gillingwater, T. and Parson, S. 816 
(2016). Survival M tor Neuron (SMN) protein is required for normal 817 
mouse liver development. Scientific Reports, 6, 34635 818 
Takahashi, N., Shimada, T., Ishibashi, Y., Sugamori, T., Hirano, Y., Oyake, N. and Murakami, Y. 819 
(2006). Cardiac involvement in Kugelberg-Welander disease: A case report and review. 820 
American Journal of the Medical Sciences, 332(6), 354-356. 821 
Tanaka, H., Nishi, S., Nuruki, K., Tanaka, N. (1977). Myocardial ultrastructural changes in 822 
Kugelberg-Welander syndrome. British Heart Journal, 39(12), 1390-1393. 823 
Tanaka, H., Uemura, N., Toyama, Y., Kudo, A. and Ohkatsu. (1976). Cardiac involvement in 824 
the Kugelbert-Welander syndrome. American Journal of Cardiology, 38(4), 528-532. 825 
Thomson, A., Somers, E., Powis, R., Shorrock, H., Murphy, K., Swoboda, K., Gillingwater, T. 826 
and Parson, S. (2016). Survival of motor neuron protein is required for normal postnatal 827 
development of the spleen. Journal of Anatomy, 230(2), 337-346. 828 
Tsai, M., Chiu, Y., Wang, S., Hsieh-Li, H., Lian, W., Li, H. (2006). Abolishing bax-dependent 829 
apoptosis shows beneficial effects on spinal muscular atrophy model mice. Molecular 830 
Therapy, 13(6), 1149-1155. 831 
Vaidla, E., Talvik, I., Kulla, A., Sibul, H., Maasalu, K., Metsvaht, T., Piirsoo, A. and Talvik, T. 832 
(2007). Neonatal spinal muscular atrophy type 1 with bone fractures and heart defect. 833 
Journal of Child Neurology, 22(1), 67-70. 834 
Vitte, J., Davoult, B., Roblot, N., Mayer, M., Joshi, V., Courageot, S., Tronche, F., Vadrot, J., 835 
Moreau, M., Kemeny, F. and Melki, J. (2004). Deletion of murine Smn exon 7 directed to 836 
liver leads to severe defect of liver development associated with iron overload. The 837 
American Journal of Pathology, 165(5), 1731-1741.  838 
Werdnig, G. (1891). Two early infantile hereditary cases of progressive muscular atrophy 839 
simulating dystrophy, but on a neural basis. Archives of Psychiatric Nursing, 22, 437–481.  840 
Page 24 of 34Journal of Anatomy
For Peer Review Only
Wijngaarde, C., Blank, A., Stam, M., Wadman, R., Van Den Berg, L. and Van Der Pol, W. 841 
(2017). Cardiac pathology in spinal muscular atrophy: a systematic review. Orphanet Journal 842 
of Rare Diseases, 12(1), 67. 843 
Wishart, T., Mutsaers, X., Riessland, M., Reimer, M., Hunter, G., Hannam, M., Eaton, S., 844 
Fuller, H., Roche, S., Somers, E., Morse, R., Young, P., Lamont, D., Hammerschmidt, M., 845 
Joshi, A., Hohenstein P., Morris, G., Parson, S., Skehel, P., Becker, T., Robinson, I., Becker, C., 846 
Wirth, B. and Gillingwater, T. (2014). Dysregulation of ubiquitin homeostasis and β-catenin 847 
signaling promote spinal muscular atrophy. The Journal of Clinical Investigation, 124(4), 848 
1821-1834. 849 
Xu, C., Denton, K., Wang, Z., Zhang, X. and Li, X. Abnormal mitochondrial transport and 850 
morphology as early pathological changes in human models of spinal muscular atrophy. 851 
DMM Disease Models and Mechanisms, 9(1), 39-49. 852 
Yang, H., Borg, T., Liu, H. and Gao, B. (2015). Interactive relationship between basement-853 
membrane development and sarcomerogenesis in single cardiomyocytes. Experimental Cell 854 
Research, 330(1), 222-232.  855 
 856 
Yang, H., Borg, T., Wang, Z., Ma, Z. and Gao, B. (2014). Role of the basement membrane in 857 
regulation of cardiac electrical properties. Annals of Biomedical Engineering, 42(6), 1148-858 
1157. 859 
Zellner, J., Spinale, F., Eble, D., Hewett, K. and Crawford, F. (1991). Alterations in myocyte 860 
shape and basement membrane attachment with tachycardia-induced heart failure. 861 
Circulation Research, 69(3), 590-600.  862 
Page 25 of 34 Journal of Anatomy
For Peer Review Only
Figure Legends  863 
 864 
Figure 1: 865 
Gross Morphology of the Heart is Altered in SMA  866 
(A) Representative images of early-symptomatic P5 hearts from heterozygous control and 867 
SMA disease mice. Scale bar represents 5mm. (B) Weight of control and SMA heart, 868 
expressed as as a % of body weight, at birth (P1), pre-symptomatic (P3), early-symptomatic 869 
(P5) and late-symptomatic ages (P8). (C) Transverse sections through the ventricles of early-870 
symptomatic P5 hearts of control and SMA mice stained with H&E, LV= left ventricle, RV = 871 
right ventricle, scale bar represents 200µm. (D) Cross-sectional area of both ventricles, 872 
expressed as a % of total cross sectional area of heart in control and SMA mice at birth (P1), 873 
pre-symptomatic (P3) and early-symptomatic (P5) ages. (E) Width of interventricular septum 874 
(IVS) in relation to body weight of control and SMA mice at birth (P1), pre-symptomatic (P3) 875 
and early-symptomatic (P5) ages. (F) Width of LV wall in relation to body weight of control 876 
and SMA mice at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) ages. 877 
Error bars, mean ±SEM (n≥3 mice per group). A two-way ANOVA was used to calculate p-878 
values. 879 
 880 
Figure 2: 881 
Cardiomyocytes are Disorganised in the SMA Heart 882 
(A) Representative micrographs in control and SMA hearts, at birth (P1), pre-symptomatic 883 
(P3) and early-symptomatic (P5) ages, immunostained for collagen IV to show the basement 884 
membrane. Images show transverse sections of whole hearts, with basement membrane 885 
indicated in white, red lines show the boundary of the compact wall of the heart, and 886 
dashed red lines highlight the orientation of cardiac muscle surrounding the left ventricle. 887 
Scale bar represents 50μm. (B) Representative micrographs of P5 control and SMA mouse 888 
hearts immunostained for collagen IV to show the basement membrane. High power 889 
representative images of collagen IV (red) and DAPI nuclei (blue) staining of the heart wall of 890 
the left ventricle and of trabeculations projecting into the lumen of the left ventricle. Scale 891 
bar represents 50µm. (C) Quantitative Western blot showing total levels of collagenIV, at 892 
birth (P1) in control and SMA hearts. Error bars, mean ±SEM (n≥3 mice per group). Unpaired 893 
student two-tailed t-test was used to calculate p-values.  894 
 895 
Figure 3: 896 
SMA Hearts Have a Decreased Number of Cardiomyocytes and an Increase in Apoptosis 897 
(A) Panels show co-immunostaining of nuclei of the cardiomyocytes with DAPI (blue) and 898 
Ki67 (red) to indicate dividing cells in control and SMA hearts, at birth (P1), pre-symptomatic 899 
(P3) and early-symptomatic (P5) ages, at low (i,ii) and high power (iii,iv). Scale bar 900 
represents 50μm. (B) Cardiomyocyte cell density, from nuclear counts, expressed per field 901 
of view in control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-902 
symptomatic (P5) ages. (C) Dividing cells (Ki67 positive nuclei) expressed as a percentage of 903 
the total number of nuclei per field of view in control and SMA hearts, at birth (P1), pre-904 
symptomatic (P3) and early-symptomatic (P5) ages. (D) Quantitative Western blot showing 905 
total levels of caspase-3 in control and SMA hearts, at birth (P1), pre-symptomatic (P3) and 906 
early-symptomatic (P5) ages.  907 
Error bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test and a two-908 
way ANOVA were used to calculate p-values.  909 
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Figure 4: 911 
Oxidative Stress is Present in SMA Hearts  912 
(A) Quantitative Western blot showing the total levles of angiotensin II receptor 1 (AT-1) in 913 
control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) 914 
ages. (B) Quantitative Western blot showing total levels of mitochondrial ATPsynthase FO 915 
subunit 6, at birth (P1) in control and SMA hearts.  916 
Error bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test was used to 917 
calculate p-values. 918 
 919 
 920 
Figure 5: 921 
Heart Microvasculature is Significantly Decreased in SMA 922 
(A) Representative micrographs of microvasculature seen in transverse sections of control 923 
and SMA hearts, stained with GSL-1, at birth (P1), pre-symptomatic (P3), early symptomatic 924 
(P5) and late-symptomatic (P8) ages. White indicates vasculature. Scale bar represents 925 
50μm. (B)High power images of microvasculature in the left ventricular wall of P5 control 926 
and SMA hearts; showing GSL-1 only (red) (i,ii) and merged with DAPI nuclei (blue) (iii,iv). 927 
Scale bar represents 50μm. (C) Quantitative Western blot showing total PECAM-1 level in 928 
control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) 929 
ages. Error bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test was 930 
used to calculate p-values.  931 
 932 
Figure 6: 933 
SMA Hearts are Congested with Blood Post-Mortem 934 
(A) Representative micrographs of transverse sections of P5 control and SMA hearts, stained 935 
with Ly76 positive cells to indicate RBC and their precursors, at low (a and b) and high power 936 
(c and d). Scale bar represents 50μm. (B) Quantification of Ly76 positive cells expressed as a 937 
percentage of cross-sectional area of the heart in control and SMA, at birth (P1), pre-938 
symptomatic (P3) and early-symptomatic (P5) ages.  939 
Error bars, mean ±SEM (n≥3 mice per group). A two-way ANOVA was used to calculate p-940 
values.  941 
 942 
Figure 7: 943 
Proposed Model for Cardiac Defects in SMA 944 
 945 
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Figure 1:  
Gross Morphology of the Heart is Altered in SMA  
(A) Representative images of early-symptomatic P5 hearts from heterozygous control and SMA disease 
mice. Scale bar represents 5mm. (B) Weight of control and SMA heart, expressed as as a % of body weight, 
at birth (P1), pre-symptomatic (P3), early-symptomatic (P5) and late-symptomatic ages (P8). (C) 
Transverse sections through the ventricles of early-symptomatic P5 hearts of control and SMA mice stained 
with H&E, LV= left ventricle, RV = right ventricle, scale bar represents 200µm. (D) Cross-sectional area of 
both ventricles, expressed as a % of total cross sectional area of heart in control and SMA mice at birth 
(P1), pre-symptomatic (P3) and early-symptomatic (P5) ages. (E) Width of interventricular septum (IVS) in 
relation to body weight of control and SMA mice at birth (P1), pre-symptomatic (P3) and early-symptomatic 
(P5) ages. (F) Width of LV wall in relation to body weight of control and SMA mice at birth (P1), pre-
symptomatic (P3) and early-symptomatic (P5) ages.  
Error bars, mean ±SEM (n≥3 mice per group). A two-way ANOVA was used to calculate p-values.  
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Cardiomyocytes are Disorganised in the SMA Heart  
(A) Representative micrographs in control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-
symptomatic (P5) ages, immunostained for collagen IV to show the basement membrane. Images show 
transverse sections of whole hearts, with basement membrane indicated in white, red lines show the 
boundary of the compact wall of the heart, and dashed red lines highlight the orientation of cardiac muscle 
surrounding the left ventricle. Scale bar represents 50µm. (B) Representative micrographs of P5 control and 
SMA mouse hearts immunostained for collagen IV to show the basement membrane. High power 
representative images of collagen IV (red) and DAPI nuclei (blue) staining of the heart wall of the left 
ventricle and of trabeculations projecting into the lumen of the left ventricle. Scale bar represents 50µm. (C) 
Quantitative Western blot showing total levels of collagenIV, at birth (P1) in control and SMA hearts. Error 
bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test was used to calculate p-values.  
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SMA Hearts Have a Decreased Number of Cardiomyocytes and an Increase in Apoptosis  
(A) Panels show co-immunostaining of nuclei of the cardiomyocytes with DAPI (blue) and Ki67 (red) to 
indicate dividing cells in control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic 
(P5) ages, at low (i,ii) and high power (iii,iv). Scale bar represents 50µm. (B) Cardiomyocyte cell density, 
from nuclear counts, expressed per field of view in control and SMA hearts, at birth (P1), pre-symptomatic 
(P3) and early-symptomatic (P5) ages. (C) Dividing cells (Ki67 positive nuclei) expressed as a percentage of 
the total number of nuclei per field of view in control and SMA hearts, at birth (P1), pre-symptomatic (P3) 
and early-symptomatic (P5) ages. (D) Quantitative Western blot showing total levels of caspase-3 in control 
and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) ages.  
Error bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test and a two-way ANOVA 
were used to calculate p-values.  
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Oxidative Stress is Present in SMA Hearts  
(A) Quantitative Western blot showing the total levles of angiotensin II receptor 1 (AT-1) in control and SMA 
hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) ages. (B) Quantitative Western blot 
showing total levels of mitochondrial ATPsynthase FO subunit 6, at birth (P1) in control and SMA hearts.  
Error bars, mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test was used to calculate p-
values.  
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Heart Microvasculature is Significantly Decreased in SMA  
(A) Representative micrographs of microvasculature seen in transverse sections of control and SMA hearts, 
stained with GSL-1, at birth (P1), pre-symptomatic (P3), early symptomatic (P5) and late-symptomatic (P8) 
ages. White indicates vasculature. Scale bar represents 50µm. (B)High power images of microvasculature in 
the left ventricular wall of P5 control and SMA hearts; showing GSL-1 only (red) (i,ii) and merged with DAPI 
nuclei (blue) (iii,iv). Scale bar represents 50µm. (C) Quantitative Western blot showing total PECAM-1 level 
in control and SMA hearts, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) ages. Error bars, 
mean ±SEM (n≥3 mice per group). Unpaired student two-tailed t-test was used to calculate p-values.  
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Figure 6:  
SMA Hearts are Congested with Blood Post-Mortem  
(A) Representative micrographs of transverse sections of P5 control and SMA hearts, stained with Ly76 
positive cells to indicate RBC and their precursors, at low (a and b) and high power (c and d). Scale bar 
represents 50µm. (B) Quantification of Ly76 positive cells expressed as a percentage of cross-sectional area 
of the heart in control and SMA, at birth (P1), pre-symptomatic (P3) and early-symptomatic (P5) ages.  
Error bars, mean ±SEM (n≥3 mice per group). A two-way ANOVA was used to calculate p-values.  
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Figure 7:  
Proposed Model for Cardiac Defects in SMA  
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